Alexion To Acquire Sweden's Wilson Therapeutics For $855M In Cash

Alexion Pharmaceuticals and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer.